According to a new AARP survey exploring the second half of life, most older adults have an optimistic outlook on life and expect their lives to improve as they get older. Nearly 9 in 10 are at least somewhat optimistic about their future, with half being extremely or very optimistic.

Today, AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement in response to the Centers for Medicare & Medicaid Services (CMS) announcement of the first Medicare negotiated drug prices as part of the 2022 prescription drug law:

AARP CEO Jo Ann Jenkins issued the following statement in response to the Medicare and Social Security Trustees Reports released today:

Today, AARP CEO Jo Ann Jenkins issued the following statement in response to President Biden’s State of the Union address:

AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement today following the House Budget Committee vote approving fiscal commission proposals that include Social Security and Medicare

AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement in response to the Centers for Medicare & Medicaid Services proposal to require federal minimum staffing levels in nursing homes.

AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement in response to the Centers for Medicare & Medicaid Services’ list of the first 10 drugs to be negotiated for lower prices by Medicare.

List prices for the 25 brand-name drugs with the highest total Medicare Part D spending in 2021 have increased by an average of 226%—or more than tripled—since they first entered the market, a new report from AARP’s Public Policy Institute shows.

AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement in response to the Centers for Medicare & Medicaid Services’ final implementation guidance of the Medicare Drug Price Negotiation Program.

AARP CEO Jo Ann Jenkins issued the following statement in response to the Medicare and Social Security Trustees’ reports released today.

AARP CEO Jo Ann Jenkins issued the following statement in response to President Biden’s State of the Union speech this evening

AARP CEO Jo Ann Jenkins issued the following statement on the importance of protecting Social Security and Medicare

AARP Executive Vice President and Chief Advocacy & Engagement Officer Nancy LeaMond issued the following statement on the Senate passage of the bipartisan 2023 omnibus bill. Earlier this month, AARP sent a letter to Congressional Leadership urging them to include important priorities for those age 50+ in any year-end legislative package.

The Centers for Medicare & Medicaid Services (CMS) released the 2023 premiums and deductibles for the Medicare Part B programs earlier today. Medicare Part B premiums will decrease by $5.20 to $164.90 next year, and deductibles will decrease $7 to $226. AARP had called for CMS to lower Part B premiums following a decline in the price and coverage of Aduhelm, which accounted for half of the premium increase in 2022.

AARP issued a statement from Jo Ann Jenkins, AARP Chief Executive Officer, after President Biden signed the Inflation Reduction Act of 2022.

AARP issued the following statement from Jo Ann Jenkins, AARP Chief Executive Officer, following the House passage of the Inflation Reduction Act of 2022

AARP issued the following statement from Jo Ann Jenkins, AARP Chief Executive Officer, following the Senate passage of the Inflation Reduction Act of 2022

AARP issued a statement from Nancy LeaMond, AARP Executive Vice President and Chief Advocacy and Engagement Officer, on the 57th anniversary of Medicare.

AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement in response to reports that the Senate reconciliation bill will extend the solvency of the Medicare program

AARP CEO Jo Ann Jenkins issued the following statement in response to the Medicare and Social Security Trustees’ reports released today

As members of Congress return to their districts for Easter recess, AARP is kicking off a new phase of its Fair Drug Prices Now campaign and pushing lawmakers to advance the prescription drug pricing provisions, including allowing Medicare to negotiate, already passed by the House, as a top priority when they return.

Today AARP launched new television and digital advertising featuring Larry Zarzecki, a retired law enforcement officer with Parkinson’s disease who was forced to sell his home in order to afford his medications. Zarzecki first shared his story in an AARP ad three years ago, but Congress’ failure to act means he has had no relief from the high cost of his treatments. As he says in the new ad, “I shouldn’t have to decide between my home or my medicine because Congress refuses to act. I’m tired of waiting for Congress.”

AARP CEO Jo Ann Jenkins released the following statement in response to President Biden’s State of the Union speech this evening, during which he called for action on high drug prices and announced new policies to improve nursing home care

AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement in response to President Biden’s remarks today about the need to lower prescription drug prices

AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement about Medicare enrollees soon having access to at-home COVID tests at no cost: